Home / Drug shortages / Doxycycline Hyclate Tablet, Delayed Release

Doxycycline Hyclate Tablet, Delayed Release — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Doxycycline Hyclate Tablet, Delayed Release (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 07/30/2026.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0591-4575-60
Dosage Form
Tablet
Presentation
Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)
Initial Posting
07/30/2026
Revised Date

FDA data resources